CRAT anticorps (N-Term)
Aperçu rapide pour CRAT anticorps (N-Term) (ABIN452873)
Antigène
Voir toutes CRAT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- This antibody detects CRAT at N-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogène
- KLH conjugated synthetic peptide selected from the N-terminal region of human CRAT
-
-
-
-
Indications d'application
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- CRAT (Carnitine O-Acetyltransferase (CRAT))
-
Autre désignation
- CRAT
-
Sujet
- CRAT is carnitine acetyltransferase (CRAT), which is a key enzyme in the metabolic pathway in mitochondria, peroxisomes and endoplasmic reticulum. CRAT catalyzes the reversible transfer of acyl groups from an acyl-CoA thioester to carnitine and regulates the ratio of acylCoA/CoA in the subcellular compartments.Synonyms: CAT1, Carnitine O-acetyltransferase, Carnitine acetylase, Carnitine acetyltransferase
-
Poids moléculaire
- 70858 Da
-
ID gène
- 1384
-
NCBI Accession
- NP_000746
-
UniProt
- P43155
-
Pathways
- Monocarboxylic Acid Catabolic Process
Antigène
-